MMI Cardiovascular Faculty Member to Lead Nuclear Cardiology Society

Dr. Mahmarian is chief of the Division of Nuclear Cardiology and CT Services at the Methodist DeBakey Heart and Vascular Center.

Medical Metrics, Inc. (MMI) is pleased to announce that MMI’s Director of Nuclear Imaging, John Mahmarian, M.D., has begun his one-year term as President of the of the American Society of Nuclear Cardiology (ANSC). As President, he is working to strengthen the role of nuclear cardiology in the diagnosis and treatment of CV diseases.

Dr. Mahmarian is chief of the Division of Nuclear Cardiology and CT Services at the Methodist DeBakey Heart & Vascular Center. He is an expert in the field of nuclear cardiology, a subspecialty of nuclear medicine that focuses on the usefulness of radioisotopes in imaging and treating heart and vascular diseases. As an MMI faculty member, Dr. Mahmarian provides expert guidance to sponsors of clinical trials on the use of imaging to guide therapy and assess risk in patients with coronary heart disease and acute chest pain syndromes. He recently led a multi-center clinical trial of stable patients following myocardial infarction based on SPECT imaging.

Dr. Mahmarian has been a member of the ASNC for 18 years and has served on numerous committees. He was Program Chair for the ASNC’s annual meeting in 2010 and is on the editorial board of the Journal of Nuclear Cardiology, a journal produced by the society.

Dr. Mahmarian’s expertise in nuclear medicine provides clinical trial sponsors with a specialized resource few core labs can match. According to MMI’s President, Tom Martin, “Dr. Mahmarian’s leadership of the ASNC illustrates the depth and breadth of scientific expertise and clinical leadership our faculty provide.”

About Medical Metrics

Medical Metrics, Inc. (MMI) is an experienced, ISO 9001-certified, independent imaging core lab for multi-center clinical trials. Through affiliation with the world-renowned Methodist DeBakey Heart & Vascular Center, MMI partners with clinical trial sponsors to conduct comprehensive imaging evaluations of treatments for cardiovascular, peripheral vascular, and neurovascular disorders. Trials range from pre-clinical and early-phase clinical studies to pivotal trials and post-approval surveillance. With an ISO-certified quality system, experienced project management team, proprietary data management platform, and luminary group of cardiovascular thought-leaders, MMI is uniquely positioned to deliver high-quality imaging core lab services for complex clinical trials.